Bo Sun

Dr. Sun’s research aims to exploit the techniques in synthetic chemistry, immunology, medicine and nanotechnology to develop safe and effective therapies for patients with cancer or other life-threatening diseases. He developed nanocrystal formulations for intraperitoneal and systemic chemotherapy during his graduate study. Dr. Sun pursued his interests in immunotherapy in the department of Radiation Oncology at UNC-Chapel Hill. His postdoctoral research was developing nano-formulations of adjuvants and immune checkpoint modulators. His work at U of Arizona focuses on the development of delivery platform of cancer vaccines for immunotherapy.